Company: HYEX
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001096906-25-001864
Chunk: 10

Company: HEALTHY EXTRACTS INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 2
Chunk 10
---
 revenue and stock-based compensation for services.  

23

Other Income (Expense)

Other income (expense) was $64,720 and $(52,565) for the three and nine months ended September 30, 2025, compared to $269,074 and $(404,703) for the three and nine months ended September 30, 2024, a decrease of $204,354, or 76%, and $352,138, or 87%, respectively. In the three months ended September 30, 2025, other income (expense) consisted of interest expense, net of interest income ($56,172) and change in fair value on derivative of $120,891. In the three months ended September 30, 2024, other income (expense) consisted of interest expense, net of interest income ($39,963) and change in fair value on derivative of $309,037. In the nine months ended September 30, 2025, other income (expense) consisted of interest expense, net of interest income $(119,988) and change in fair value on derivative of $67,423. In the nine months ended September 30, 2024, other income (expense) consisted of interest expense, net of interest income $(131,268) and change in fair value on derivative of $(273,436). Change in fair value on derivative was related to the conversion of convertible debts into common stock shares. 

Net Income (Loss)

Net income (loss) was $(395,394) and $(727,133), or $(0.06) and $(0.11) per share, for the three and nine months ended September 30, 2025, compared to $354,466 and $(393,742), or $0.12 and $(0.13) per share, for the three and nine months ended September 30, 2024.

Our net income (loss) varies from period to period primarily because of the change in fair value on derivative and our increase in general and administrative expenses.

Liquidity and Capital Resources

Introduction

During the nine months ended September 30, 2025, we had negative operating cash flows. Our cash on hand as of December 31, 2024 was $112,020 and as of September 30, 2025 was $189,452. We also had positive net cash from operations for the year ended December 31, 2024, but we still have both short-